Key points A 68-year-old woman presented to the emergency department of a rural hospital in southern Alberta 1 hour after acute onset of speech difficulties and weakness in her right upper and lower ...

Against all the odds, Roche's Genentech unit has won FDA approval for its clot-busting drug TNKase as a treatment for acute ischaemic stroke, after all but abandoning the project a couple of years ago ...

Add Yahoo as a preferred source to see more of our stories on Google. Lumosa Therapeutics' small molecule-peptide conjugate Lumosa Therapeutics has posted positive results from two independent Phase ...

Add Yahoo as a preferred source to see more of our stories on Google. The AHA's 2026 report marks a decrease in CVD deaths A new report from the American Heart Association (AHA) has found that US ...

The approval marks the first new stroke treatment authorized in nearly 27 years, offering an additional option for managing acute ischemic stroke in Canada. MISSISSAUGA, ON, Dec. 17, 2025 /CNW/ - ...

Cette approbation représente le premier nouveau traitement pour l'accident vasculaire cérébral autorisé depuis près de 27 ans, offrant une option supplémentaire pour la prise en charge de l'AVC ...

Please provide your email address to receive an email when new articles are posted on . The findings were presented in a poster at the American College of Allergy, Asthma & Immunology Annual ...

The Business Research Company's Tissue Plasminogen Activator Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Latest Report Explores ...

The pairing of two Bristol Myers Squibb immunotherapies is now permitted for the first-line treatment of two types of gastrointestinal cancers, after regulatory decisions handed out this past week ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ischemic stroke have been granted approval by the US Food and Drug ...